Functional polymorphisms within pro-inflammatory cytokine genes such as Interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) may increase the risk of depression and are associated with reduced responsiveness to conventional antidepressant therapy (Yu et al., 2003; Jun et al., 2003). Here, IL1B is linked to major depressive disorder.